Literature DB >> 25810164

Successful Treatment Toward Gastrointestinal Stromal Tumors with Aggressive Behavior.

Landolsi Sana1, Mannai Saber.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25810164     DOI： 10.1007/s12029-015-9706-3

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  21 in total

1.  Advances in the surgical management of gastrointestinal stromal tumor.

Authors:  Umer I Chaudhry; Ronald P DeMatteo
Journal:  Adv Surg       Date:  2011

2.  GIST of pancreas.

Authors:  Z Krska; M Pesková; C Povýsil; J Horejs; E Sedlácková; Z Kudrnová
Journal:  Prague Med Rep       Date:  2005

3.  Malignant stromal tumor, so called "gastrointestinal stromal tumor", with rhabdomyomatous differentiation occurring in the gallbladder.

Authors:  Makoto Furihata; Takahiro Fujimori; Johji Imura; Yuko Ono; Tadashi Furihata; Mitsugi Shimoda; Masato Kato; Junji Kita; Yasuo Ohkura; Keiichi Kubota
Journal:  Pathol Res Pract       Date:  2005       Impact factor: 3.250

4.  Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132.

Authors:  Dian Wang; Qiang Zhang; Charles D Blanke; George D Demetri; Michael C Heinrich; James C Watson; John P Hoffman; Scott Okuno; John M Kane; Margaret von Mehren; Burton L Eisenberg
Journal:  Ann Surg Oncol       Date:  2011-12-28       Impact factor: 5.344

5.  Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour.

Authors:  P Hohenberger; U Ronellenfitsch; O Oladeji; D Pink; P Ströbel; E Wardelmann; P Reichardt
Journal:  Br J Surg       Date:  2010-08-20       Impact factor: 6.939

6.  Soft tissue sarcoma, version 2.2014.

Authors:  Margaret von Mehren; R Lor Randall; Robert S Benjamin; Sarah Boles; Marilyn M Bui; Ephraim S Casper; Ernest U Conrad; Thomas F Delaney; Kristen N Ganjoo; Suzanne George; Ricardo J Gonzalez; Martin J Heslin; John M Kane; Joel Mayerson; Sean V McGarry; Christian Meyer; Richard J O'Donnell; Alberto S Pappo; I Benjamin Paz; John D Pfeifer; Richard F Riedel; Scott Schuetze; Karen D Schupak; Herbert S Schwartz; Brian A Van Tine; Jeffrey D Wayne; Mary Anne Bergman; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2014-04       Impact factor: 11.908

7.  Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST.

Authors:  Alessandro Gronchi; Marco Fiore; Francesca Miselli; Maria Stefania Lagonigro; Paola Coco; Antonella Messina; Silvana Pilotti; Paolo Giovanni Casali
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

8.  Post-imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients?

Authors:  C Mussi; U Ronellenfitsch; J Jakob; E Tamborini; P Reichardt; P G Casali; M Fiore; P Hohenberger; A Gronchi
Journal:  Ann Oncol       Date:  2009-07-23       Impact factor: 32.976

9.  Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.

Authors:  Burton L Eisenberg; Jonathan Harris; Charles D Blanke; George D Demetri; Michael C Heinrich; James C Watson; John P Hoffman; Scott Okuno; John M Kane; Margaret von Mehren
Journal:  J Surg Oncol       Date:  2009-01-01       Impact factor: 3.454

10.  Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.

Authors:  Ronald P Dematteo; Karla V Ballman; Cristina R Antonescu; Robert G Maki; Peter W T Pisters; George D Demetri; Martin E Blackstein; Charles D Blanke; Margaret von Mehren; Murray F Brennan; Shreyaskumar Patel; Martin D McCarter; Jonathan A Polikoff; Benjamin R Tan; Kouros Owzar
Journal:  Lancet       Date:  2009-03-18       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.